Evidence map›Paper›PMID 32670577›Full record

ArticleClinical & translational immunology2020

Novel pathogenic mutations identified in the first Chinese pedigree of complete C6 deficiency.

Philip H Li, William Wy Wong, Evelyn Ny Leung, Chak-Sing Lau, Elaine Au

Open access · goldAbstract read
In one paragraph

Article in Clinical & translational immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Philip H LiDivision of Rheumatology & Clinical Immunology Department of Medicine Queen Mary Hospital The University of Hong Kong Hong Kong.ORCID https://orcid.org/0000-0002-9155-9162
William Wy WongDivision of Clinical Immunology Department of Pathology Queen Mary Hospital Hong Kong.
Evelyn Ny LeungDivision of Clinical Immunology Department of Pathology Queen Mary Hospital Hong Kong.
Chak-Sing LauDivision of Rheumatology & Clinical Immunology Department of Medicine Queen Mary Hospital The University of Hong Kong Hong Kong.
Elaine AuDivision of Clinical Immunology Department of Pathology Queen Mary Hospital Hong Kong.
Queen Mary Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesComplete C6 deficiency (C6Q0) is a rare primary immunodeficiency leading to increased susceptibility to recurrent

methodsTwo variants in

resultsThree C6Q0 patients were identified with near-absent C6 levels, absent CH50/AH50 activity and compound heterozygous for two nonsense mutations in the

conclusionsWe report on two compound heterozygous mutations in

Indexed as

C6ChinesecomplementdeficiencyimmunodeficiencyNeisseria

Identifiers

PMID32670577
PMCPMC7343556
OpenAlexW3041562881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.